Endacea, Inc.
Records under this name other than the patents Endacea, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,247,231 | Methods and compositions for producing antigenic responses Lapsed on the fee record Ended Aug 21, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 21, 2020 | From the USPTO record |
| US 7,247,639 | A1 adenosine receptor antagonists Lapsed on the fee record Ended Jul 24, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jul 24, 2019 | From the USPTO record |
| US 7,202,252 | A1 adenosine receptor antagonists Lapsed on the fee record Ended Apr 10, 2015 · From the USPTO record | Lapsed on the fee record | Ended Apr 10, 2015 | From the USPTO record |
| US 6,159,701 | Method and compositions for treating and diagnosing tumors using adenosine receptor activated cells Lapsed on the fee record Ended Dec 12, 2012 · From the USPTO record | Lapsed on the fee record | Ended Dec 12, 2012 | From the USPTO record |
| US 6,117,445 | Methods for the prevention and treatment of fibrosis and sclerosis Lapsed on the fee record Ended Sep 12, 2012 · From the USPTO record | Lapsed on the fee record | Ended Sep 12, 2012 | From the USPTO record |
| US 6,117,998 | A1 adenosine receptor antagonists Lapsed on the fee record Ended Sep 12, 2012 · From the USPTO record | Lapsed on the fee record | Ended Sep 12, 2012 | From the USPTO record |
| US 7,423,041 | A1 adenosine receptor antagonists Lapsed on the fee record Ended Sep 9, 2012 · From the USPTO record | Lapsed on the fee record | Ended Sep 9, 2012 | From the USPTO record |
| US 6,680,052 | Methods of inhibiting tumor growth using adenosine receptor activated cells Lapsed on the fee record Ended Jan 20, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jan 20, 2012 | From the USPTO record |
| US 6,495,687 | A1 adenosine receptor antagonists Lapsed on the fee record Ended Dec 17, 2010 · From the USPTO record | Lapsed on the fee record | Ended Dec 17, 2010 | From the USPTO record |
| US 6,489,332 | A1 adenosine receptor antagonists Lapsed on the fee record Ended Dec 3, 2010 · From the USPTO record | Lapsed on the fee record | Ended Dec 3, 2010 | From the USPTO record |